Literature DB >> 19933929

Proton pump inhibitors and clopidogrel: putting the interaction in perspective.

David N Juurlink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19933929     DOI： 10.1161/CIRCULATIONAHA.109.907295

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  19 in total

1.  Trends in the coprescription of proton pump inhibitors with clopidogrel: an ecological analysis.

Authors:  David N Juurlink; Tara Gomes; J Michael Paterson; Chelsea Hellings; Muhammad M Mamdani
Journal:  CMAJ Open       Date:  2015-11-26

Review 2.  Effects of proton pump inhibitors on adverse gastrointestinal events in patients receiving clopidogrel: systematic review and meta-analysis.

Authors:  Chun Shing Kwok; Ramanpreet Singh Nijjar; Yoon Kong Loke
Journal:  Drug Saf       Date:  2011-01-01       Impact factor: 5.606

3.  A Retrospective Cohort Study Comparing In-Person and Telemedicine-Based Opioid Agonist Treatment in Ontario, Canada, Using Administrative Health Data.

Authors:  Kristen A Morin; Matthiew D Parrotta; Joseph K Eibl; David C Marsh
Journal:  Eur Addict Res       Date:  2021-03-11       Impact factor: 3.015

4.  The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro.

Authors:  V Ancrenaz; J Desmeules; R James; P Fontana; J-L Reny; P Dayer; Y Daali
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

5.  Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis.

Authors:  Katsiaryna Bykov; Sebastian Schneeweiss; Robert J Glynn; Murray A Mittleman; David W Bates; Joshua J Gagne
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

Review 6.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

Review 7.  New antithrombotic agents--insights from clinical trials.

Authors:  Jeremy S Paikin; John W Eikelboom; John A Cairns; Jack Hirsh
Journal:  Nat Rev Cardiol       Date:  2010-06-29       Impact factor: 32.419

Review 8.  Antithrombotics for secondary prevention of noncardioembolic ischaemic stroke.

Authors:  Bruce A Warden; Alana M Willman; Craig D Williams
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

Review 9.  Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis.

Authors:  J-L Reny; C Combescure; Y Daali; P Fontana
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

Review 10.  Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherence.

Authors:  Kumaran Kolandaivelu; Deepak L Bhatt
Journal:  Nat Rev Cardiol       Date:  2010-06-01       Impact factor: 32.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.